Tag Archives: Physician

Study: Future of Personalized Medicine

By Jeff Schindler | Published: July 27, 2010
An increased focus on targeted medicine has become a staple for all facets of healthcare, from drug developers to consumers to pharma companies. Gerson Lehrman and Bloomberg jointly commissioned a survey that gauged the reactions and predictions of this trend from 52 leading US physicians. The survey covered a number of topics to assess which [...]
Posted in R&D | Also tagged , , , , , , | 1 Comment

Reps Allowed Access; Just Make an Appointment

By George Koroneos | Published: March 17, 2010
Image by Joseph Cote via Flickr SK&A released the results of its latest physician survey, and it turns out that most docs are happy to meet with sales reps as long as they make an appointment in advance. In fact, 98 percent of offices that allow sales reps to make office calls see 20 reps per week. “That’s [...]
Posted in Sales | Also tagged , , , , , , , , | 1 Comment

A Lead Drug on the Way? All Eyes on FDA

By Brittany Agro | Published: November 4, 2009
For NeurogesX, a small biopharma company based in San Mateo, CA, time does not stand still. Every day preceding November 16 brings its flagship drug, Qutenza, one step closer to approval. Until then, the company has turned its energies to finalizing its US commercialization strategy. (NeurogesX previously entered into a commercialization agreement with Astellas Pharma [...]
Posted in Strategy | Also tagged , , , | Leave a comment